Loading clinical trials...
Loading clinical trials...
A Study to Evaluate the Safety, Tolerability, Systemic Pharmacokinetic Profile and Pharmacodynamics of Single and Repeat Inhaled Doses of GSK961081 in Healthy Subjects
Conditions
Interventions
GSK961081 15mcg SD
GSK961081 3mcg SD
+8 more
Locations
1
United Kingdom
GSK Investigational Site
London, United Kingdom
Start Date
November 7, 2005
Primary Completion Date
October 4, 2006
Completion Date
October 4, 2006
Last Updated
October 6, 2021
NCT06831994
NCT02755974
NCT05050591
NCT05913765
NCT05592847
NCT00683722
Lead Sponsor
Theravance Biopharma
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions